MENU
+Compare
SNPX
Stock ticker: NASDAQ
AS OF
Dec 20, 04:59 PM (EDT)
Price
$3.06
Change
+$0.50 (+19.46%)
Capitalization
4.15M

SNPX Synaptogenix Forecast, Technical & Fundamental Analysis

Industry Biotechnology
SNPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for SNPX with price predictions
Dec 20, 2024

SNPX in -5.35% downward trend, sliding for three consecutive days on December 19, 2024

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where SNPX declined for three days, in of 273 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

SNPX broke above its upper Bollinger Band on December 02, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for SNPX entered a downward trend on November 26, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where SNPX's RSI Oscillator exited the oversold zone, of 22 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 49 cases where SNPX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on December 20, 2024. You may want to consider a long position or call options on SNPX as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SNPX just turned positive on December 20, 2024. Looking at past instances where SNPX's MACD turned positive, the stock continued to rise in of 38 cases over the following month. The odds of a continued upward trend are .

SNPX moved above its 50-day moving average on December 20, 2024 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SNPX advanced for three days, in of 178 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.325) is normal, around the industry mean (14.556). P/E Ratio (3.483) is within average values for comparable stocks, (87.563). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.739). SNPX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.000) is also within normal values, averaging (256.215).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SNPX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SNPX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
SNPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

SNPX is expected to report earnings to rise 107.41% to -56 cents per share on May 31

Synaptogenix SNPX Stock Earnings Reports
Q1'23
Est.
$-0.56
Q4'22
Est.
$-0.27
Q3'22
Beat
by $0.12
Q2'22
Missed
by $13.02
Q1'22
Missed
by $11.24
The last earnings report on March 01 showed earnings per share of -27 cents, meeting the estimate of -27 cents. With 96.24K shares outstanding, the current market capitalization sits at 4.15M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1185 Avenue of the Americas
Phone
+1 973 242-0005
Employees
5
Web
https://www.synaptogen.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRGO2.650.18
+7.29%
Freightos Limited
ELF128.66-0.43
-0.33%
elf Beauty
CGNT8.67-0.03
-0.34%
Cognyte Software Ltd
GTX9.01-0.09
-0.99%
Garrett Motion
ATXI1.77-0.03
-1.67%
Avenue Therapeutics

SNPX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SNPX has been closely correlated with NCNA. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if SNPX jumps, then NCNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNPX
1D Price
Change %
SNPX100%
+19.69%
NCNA - SNPX
92%
Closely correlated
N/A
RNAC - SNPX
91%
Closely correlated
-1.30%
AGEN - SNPX
91%
Closely correlated
+2.54%
ALLR - SNPX
87%
Closely correlated
-3.87%
NRXP - SNPX
84%
Closely correlated
-1.32%
More

Groups containing SNPX

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNPX
1D Price
Change %
SNPX100%
+19.69%
SNPX
(7 stocks)
12%
Poorly correlated
+1.85%